Related Articles
PD‑L1/PD‑1 blockade in breast cancer: The immunotherapy era (Review)
miR‑30a inhibits epithelial‑mesenchymal transition and metastasis in triple‑negative breast cancer by targeting ROR1
Expression of programmed death ligand 1 in patients with triple‑negative breast cancer: Association with clinicopathological parameters
GROα overexpression drives cell migration and invasion in triple negative breast cancer cells
CSF1 is involved in breast cancer progression through inducing monocyte differentiation and homing